Wolfe Research analyst Sam Margolin downgrades ConocoPhillips (NYSE:COP) from Outperform to Peer Perform.
Truist Securities Upgrades Gilead Sciences to Buy, Raises Price Target to $91
Truist Securities analyst Robyn Karnauskas upgrades Gilead Sciences (NASDAQ:GILD) from Hold to Buy and raises the price target from $76 to $91.